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Genetic insights into serotonin function
Targeted disruption of the genes for the 5-HT 1B and 5-HT 2c serotonin
receptors and monoamine oxidase A have confirmed pharmacological
experiments and revealed unexpected behavioral roles for serotonin.
Serotonin (5-hydroxytryptamine, 5-HT) is a biogenic
monoamine found in a wide variety of sites in the central
and peripheral nervous systems. Serotonergic signaling
appears to play a key role in the generation and modula-
tion of a broad array of behaviors, including sleep, loco-
motion, feeding, vomiting, addiction, aggression, sexual
activity and affect [1]. It has been the focus of intense
investigation because of these roles and the extensive
opportunities it provides for therapeutic manipulation.
In recent years, our view of serotonin has become
tremendously complex as we have learned that multiple
specific proteins mediate each of the steps of receptor
binding, re-uptake and degradation. The advent of mol-
ecular techniques has provided a structural basis for sub-
classifying and expanding the large family of serotonin
receptors; at present, at least 15 mammalian serotonin
receptors have been identified [2]. A wide functional
diversity exists within this family: serotonin receptors
may be ionotropic or metabotropic, and may couple via
G proteins to numerous intracellular signaling pathways.
Serotonin receptors also display specific patterns of
expression both during development and in the mature
animal. The pathways involved in serotonin re-uptake
and degradation add further layers of complexity to
serotonin biology.
The classical pharmacological techniques of using selec-
tive agonists, antagonists and inhibitors provided the ini-
tial basis for categorizing the receptors, transporters and
degrading enzymes involved in serotonergic pathways.
But the complexity of the system has overwhelmed the
armamentarium of selective drugs, leaving many proteins
without specific probes of their function. Recent advan-
ces in the field have exploited deliberate or naturally
occurring disruptions of the genes that code for proteins
important to serotonergic transmission. Four recent con-
tributions [3-6] describe the effects of disrupting the
genes encoding the 5-HT 1B and 5-HT 2c receptors in
mice, and the monoamine oxidase A (MAOA) genes in
mouse and human (Table 1).
5-HTls knockout - locomotion and aggression
The 5-HTIB receptor was the first protein involved in
serotonergic signaling to have its gene disrupted [3]. The
5-HT1B receptor is expressed in the basal ganglia, central
gray, hippocampus, amygdala and raphe nuclei; it is tar-
geted primarily to presynaptic terminals, where it can
inhibit neurotransmitter release. Highly specific agonists
and antagonists are not available for 5-HT1B receptors,
but pharmacological experiments suggest that 5-HT1B
receptor activation may increase anxiety and locomotion
and decrease food intake, sexual activity and aggression.
Targeted disruption was achieved by deleting a fragment
of the coding sequence, and functional inactivation of the
5-HTB receptor was confirmed by autoradiography
with 'lI-cyanopindolol, which binds 5-HTIB receptors,
along with appropriate blockers of non-5-HTIB binding
sites. Heterozygote animals expressed the same levels of
receptor as wild-types, suggesting that a feedback mecha-
nism may regulate the transcriptional activity of the gene.
Two of the behaviors postulated to be modulated by
5-HT1B receptors were analyzed: locomotion and aggres-
sion. Untreated wild-type and homozygous mutant (5-
HTB/-) mice were found to display similar levels of
locomotor activity in an open field. However, when
treated with the 5-HT 1 agonist RU24969, the 5-HTiB/-
mice displayed no change in activity, whereas wild-type
mice doubled their activity. This result confirmed pre-
vious pharmacological studies indicating that RU24969
operates through 5-HT1B receptors.
The aggressiveness of 5-HTIB/- male mice was assessed
by isolating them for four weeks and then exposing them
to a non-isolated male wild-type intruder mouse. The
latency and number of attacks displayed by the knockout
mice during a three-minute period were used as indices
of aggression. The 5-HTiB/- mice, when compared with
wild-type mice, exhibited faster, more intense and more
frequent attacks. For example, 46 % of the 5-HTIB/-
mice attacked the intruder within 10 seconds of intro-
duction, whereas no heterozygous or wild-type mice
attacked during this interval. Tail rattling, an aggressive
display, was also more frequent in 5-HTIB/- mice.
These experiments suggest an involvement of 5-HTIB
receptors in the modulation of aggressive behavior. Elto-
prazine and fluprazine, drugs classified as serenics because
of their anti-aggressive properties, are believed to operate
as agonists of 5-HT 1 receptors. The lack of subtype-
specific antagonists has impeded specific identification of
the molecular target of such serenics; the availability of
5-HTB/- mice should allow more detailed evaluation of
the pathways leading to aggression.
5-HT2c knockout - seizures and overeating
The 5-HT2 c gene knockout was generated by insertion
of a stop codon that eliminated the carboxyl terminus of
the protein [4]. The 5-HT2 c gene is X-linked; brains of
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mutant males were devoid of 5-HT 2c immunoreactivity,
and mRNA from such males failed to produce functional
receptor when injected into Xenopus oocytes.
The patterns of expression of 5-HT2C receptors in the
hippocampus and spinal cord suggest that they might
modulate memory and nociception. However, hippo-
campal LTP and nociceptive thresholds were the same
in wild-type and 5-HT2c/ - mice. Video monitoring
revealed that 5-HT2 c-/ mice displayed spontaneous epi-
leptic seizures that were sometimes fatal; survival plots
indicated that almost half of the mice had died by 25
weeks of age. Metrazol, a y-amino butyric acid (GABA)
receptor antagonist, was used to quantify seizure suscepti-
bility. Relative to wild-type mice, the 5-HT2c/ - mice
displayed a reduced seizure threshold and a more rapid
progression through the tonic-clonic phase of the seizure.
The unexpected susceptibility of 5-HT2 c'- mice to
epileptic seizures raises the possibility that this receptor
participates in the modulation of neuronal network
excitability. The ability to affect the seizure characteristics
of normal mice with 5-HT2 c ligands suggests that the
phenotype of the 5-HT2 c- - mice is not a result of
chronic compensation by other receptors for the loss of
5-HT 2c receptors.
5-HT2 c-/ - mice were also noted to be significantly
heavier than matched wild-type controls. Close analysis
of their feeding behavior indicated that the weight
increase was due entirely to increased intake, and not to
a metabolic derangement that increases the efficiency
of caloric storage. The serotonergic agonist 1-(3-chloro-
phenyl)piperazine (mCPP) drastically reduced food intake
by wild-type mice, but had no effect on food intake by
5-HT2 c/ - mice, demonstrating that appetite suppressants
may operate via 5-HT 2c receptors.
MAOA knockout - aggression and elevated brain serotonin
MAOA is a mitochondrial enzyme that degrades and
inactivates biogenic amines, including serotonin, dopa-
mine and norepinephrine. MAOA-deficient mice were
generated accidentally by the replacement of exons 2 and
3 of the MAOA gene with a -interferon transgene [5].
Brain and liver MAOA activity was abolished in the
mutant mice.
MAOA-deficient mice displayed a wide array of behav-
ioral abnormalities, from birth through to maturity.
Importantly, all of these abnormalities could be suppres-
sed by administration of a serotonin synthesis inhibitor,
whereas catecholamine synthesis suppression had no
effect. Thus, even though both serotonin and norepi-
nephrine levels were elevated in MAOA-deficient mice,
the observed behavioral abnormalities are likely to be
specifically the result of decreased serotonin degradation.
Behavioral abnormalities included tremulousness, hyper-
active startle responses, violent motions during sleep and
abnormal posture. Increased male aggressiveness was doc-
umented by resident-intruder tests and increased wound-
ing between male cage-mates. Interestingly, MAOA-
deficient mice fail to develop cortical whisker barrels,
indicating that MAOA plays a developmental role in the
nervous system. The fact that MAOA-deficient mice have
abnormal brain development leaves open the question of
whether the behavioral abnormalities seen in the adult
animals are due to abnormal monoamine metabolism or
to structural abnormalities.
MAOA disruption and human aggression
The behavior of the MAOA-deficient mice described
above provides a timely complement to the description
of a human mutation of MAOA [6]. The X-linked muta-
tion was detected in several kindred males with border-
line mental retardation and histories of abnormal behav-
ior including impulsive aggression, arson, attempted rape
and exhibitionism. Affected males exhibit markedly dis-
turbed monoamine metabolism and an absence of func-
tional MAOA in cultured fibroblasts. A nonconservative
point mutation was found in all affected males and all
carrier females; the mutation introduces a stop codon at
position 296 of the deduced amino-acid sequence. The
inhibition of MAOA in adult humans has not been
reported to induce aggressive behavior; thus, the abnor-
mal behavior seen in MAOA-deficient men may be a
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consequence of structural or compensatory changes
incurred by defective monoamine metabolism during
development.
Accurate interpretation of experimental results derived
from knockout animals requires the exercise of several
cautions. A major concern with the study of adult knock-
out animals is that the altered behavior or phenotype
may be due a developmental abnormality. It is becoming
increasingly evident that many neurotransmitters and
receptors are expressed at early periods of neural develop-
ment, and it is likely that they participate in the structural
organization of the nervous system. This is well illus-
trated by the cortical abnormalities described by Cases et
al. [5] in MAOA-deficient mice. Another concern is that
any abnormal phenotype may not be a direct result of the
deficient protein, but instead a result of compensatory
changes occurring in other related systems. In this regard,
knockouts may provide a particularly useful model for
the study of human mutations, because, in both cases the
genomic perturbation operates throughout development.
An additional shortcoming of current knockout experi-
ments is the inability to provide region-specific control
of the disruption. Localized delivery of agonists and
antagonists has played a crucial part in the analysis of the
neurobiology of behavior; with the exception of proteins
with confined expression patterns, it is difficult to define
the anatomical site at which a knockout exerts its effect.
Happily, new techniques might prove useful in addressing
some of these concerns. Specifically, the ability to use
native and exogenous promoters to control the expres-
sion of specifically targeted genes may allow region-spe-
cific and temporal control of protein expression (more
detailed descriptions of how these systems might be used
to create tissue specific inducible knockouts are provided
elsewhere [7]). Systems that may prove useful include the
tetracycline-responsive inducible promoter [8-10], and
the loxP-cre method of inducibly deleting sections of
DNA [11]. We can confidently expect much more light
to be shed on serotonergic pathways in the near future.
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